Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Holding(s) in Company

April 15, 2024
RNS Number : 6814K Renalytix PLC 15 April 2024   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing

Completion of Financing and Total Voting Rights

April 15, 2024
RNS Number : 6784K Renalytix PLC 15 April 2024     NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO  THE UNITED STATES ,  CANADA ,  AUSTRALIA ,  JAPAN  OR THE  REPUBLIC OF SOUTH AFRICA  OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 15, 2024
RNS Number : 6091K Stifel Nicolaus Europe Limited 15 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Holding(s) in Company

April 12, 2024
RNS Number : 5019K Renalytix PLC 12 April 2024   S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares: Renalytix PLC 1b. Please indicate if the issuer is a non- UK issuer    (please mark with an "X"

Rule 2.9 Announcement

April 12, 2024
RNS Number : 3586K Renalytix PLC 12 April 2024   Renalytix plc ("Renalytix" or the "Company")   Rule 2.9 Announcement   LONDON and SALT LAKE CITY -   12 April 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) , in   accordance with Rule 2.9 of the City Code on Takeovers and Mergers and further

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 10, 2024
RNS Number : 0147K Stifel Nicolaus Europe Limited 10 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Issue of Shares

April 10, 2024
RNS Number : 0298K Renalytix PLC 10 April 2024   Renalytix plc ("Renalytix" or the "Company")   Issue of Shares   LONDON and SALT LAKE CITY -   10 April 2024 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) , announces the repayment of $1.06 million of principal and interest amount due under the

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 9, 2024
RNS Number : 8412J Stifel Nicolaus Europe Limited 09 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

April 8, 2024
RNS Number : 6587J Stifel Nicolaus Europe Limited 08 April 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Financing with Expected Size of up to $4 Million

April 8, 2024
RNS Number : 6496J Renalytix PLC 08 April 2024   NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES , CANADA , AUSTRALIA , JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A
Displaying 11 - 20 of 360